3 Undervalued US Stocks Best in Class

Ahead of tomorrow's US Presidential Election we highlight three American stocks with clear advantages over their competitors - but who are currently trading at less than fair value

Emma Wall 7 November, 2016 | 10:52AM
Facebook Twitter LinkedIn

On Friday, the US stock market fell for the ninth day in a row. It is hardly surprising that in the run up to one of the most controversial US Presidential elections in modern history the market has got the jitters.

It is important to note that despite these consecutive falls the S&P 500 has not moved much – down just 3 points on Friday to 2,085 it sits at similar levels to where it was a year ago, and is up from 2,013 at the start of the year.

However, there are sectors of the market which have been hurt in this election campaign – and many more that lie at risk dependent on the outcome of tomorrow’s vote. Pharmaceutical stocks have been significantly devalued following Hillary Clinton’s promise to crackdown on drug price hikes, and should Donald Trump come to power, his protectionist stance will damage global traders.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
Amgen Inc203.13 USD-2.27Rating
HollyFrontier Corp36.71 USD0.74Rating
The Walt Disney Co171.14 USD-3.01Rating

About Author

Emma Wall  is former Senior International Editor for Morningstar